Title : Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats.

Pub. Date : 2015 Apr

PMID : 25648286






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Exenatide increased insulin AUC by 224%, 258%, 331% and 93%, exenatide extended-release by 127%, 169%, 178% and 95%, and sitagliptin by 32%, 69%, 62%, and 43%, respectively. Exenatide insulin Felis catus